First drug proven to slow Alzheimer's won't be available to most patients for several months

Leqembi, the first drug shown to slow Alzheimer’s, has been approved by the FDA, but most U.S. patients will not be able to receive treatment for months.

Related Keywords

Japan ,United States ,Japanese ,America ,Los Angeles ,Libby Holman ,Robert Egge ,Sarah Kremen ,America Health Insurance ,Centers For Medicare ,Alzheimer Association ,Medicaid Services ,Drug Administration ,Medicare Advantage ,Health Insurance ,